Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Amateur Traders Corner -- Ignore unavailable to you. Want to Upgrade?

To: JustTradeEm who wrote (18247)	1/10/2002 4:57:51 PM
From: Tom Hua	Read Replies (2) \| Respond to of 19633

JB, did it really trade up to 57? now printing 48s. Regards, Tom

To: JustTradeEm who wrote (18247)	1/10/2002 4:58:56 PM
From: Bob	Respond to of 19633

JB I had IGEN long at 18 sold at 32 last fall. :-( Roche Ordered to Pay $501 Mln in Igen Licensing Case Greenbelt, Maryland: Roche Holding AG must pay $501 million in damages to Igen International Inc. for underpaying licensing fees on blood-testing technology used in Roche's diagnostic equipment, jurors ruled. Jurors in federal court in Greenbelt, Maryland, deliberated more than four days before finding Roche's diagnostic unit deliberately underpaid royalties on the technology, used to test bodily fluids for cancer and thyroid problems. The jury also found Roche engaged in unfair business practices and that Roche's license rights to the technology should be terminated. Medical-industry analysts have been closely following the 10- week trial because Roche's license to Igen's technology is estimated to be worth more than $1 billion, according to testimony in the case. Roche is the No. 1 maker of diagnostic products in the world. ``The license is the most attractive feature of this whole thing,'' said Bob Parente, an analyst with Leerink Swann Inc., a Boston investment firm who has monitored the trial. Also look at MATK, they sell an additive for infant formula. Regards, BobP